85.1%
JAK inhibitorIL-12/23anti-IL-12/23anti-TNFulcerative colitisrheumatoid arthritispolymyalgia rheumaticaileocolonic diseaseInflammatory bowel diseaseGRC+3 more
…s switches were anti-TNF to anti-IL-12/23 (n=5) and IL-12/23 to JAK inhibitor (n=4). Non-medication-related actions (e.g. investigations or r…